Skip to content

Effect of esketamine on postoperative delirium in elderly patients undergoing joint replacement under general anesthesia

Effect of esketamine on postoperative delirium in elderly patients undergoing joint replacement under general anesthesia

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104545
Enrollment
Unknown
Registered
2025-06-18
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Esketamine group:Esketamine 0.25mg/kg was administered during induction intubation and esketamine 0.1mg/kg/h was pumped continuously during anesthesia maintenance until the end of surgery.
Dexmedetomidine group:During induction of anesthesia, 0.5ug/kg/h dexmedetomidine was administered for 10 minutes, then 0.2-0.7ug/kg/h dexmedetomidine was pumped continuously during maintenance of anes
Normal saline group:Equal dose of normal saline was given during induction intubation, and continuous pumping of normal saline was given during anesthesia maintenance until the end of the operation.

Sponsors

The second affiliated hospital of guangzhou medical university, Guangzhou, China.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 65-80 years old; (2) Orthopedic joint replacement surgery under general anesthesia should be performed at an appropriate time. (3) Preoperative Amstedin scale >= 12 points; (4) American Society of Anesthesiologists (ASA) Grade I to III

Exclusion criteria

Exclusion criteria: (1) illiteracy; (2) deafness (3) Patients at serious risk of elevated blood pressure or intracranial pressure (e.g Arterial dissection, intracranial aneurysm, etc.) (4) Poorly controlled or untreated hyperemia Hypertensive patients (high blood pressure in motor pulse, excessive resting systolic/diastolic pressure) 180/100mmHg); ; (5) Abnormal liver and kidney function, abnormal liver function is defined as glutamic acid transamination Enzyme (AST) and/or alanine aminotransferase (ALT) levels exceed 1.5 times the upper limit of normal (ULN), and renal dysfunction is defined as serum creatinine (Cr) >= 1.5 times ULN. ; (6) Body mass index >30kg/m^2; (7) Patients with mental illness or language communication barriers Sedative drugs, antidepressants and other drugs commonly used to affect drug metabolism; (8) untreated or Patients with undertreated hyperthyroidism (hyperthyroidism); (9) Acute closed Angle blue A light-eyed patient; (10) Complicated with ischemic heart disease and congestive heart failure Patient; (11) Diseased sinus syndrome, second or third degree heart block, or clinically significant Patients with sinus bradycardia; (12) The activity of esketamine and dexmedetomidine Patients allergic to either or all excipients

Design outcomes

Primary

MeasureTime frame
Postoperative delirium;perioperative haemodynamics;

Secondary

MeasureTime frame
Postoperative anxiety;Postoperative pain;Postoperative sleep quality;

Countries

China

Contacts

Public Contactlingzhi wang

The second affiliated hospital of guangzhou medical university, Guangzhou, China.

wlz4009@163.com+86 136 3240 7340

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026